Citadel Advisors’s Kronos Bio KRON Stock Holding History

Citadel Advisors’s Portfolio KRON Stock Details KRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-100	Closed	-$95	–	15085
2024 Q4	$95	Hold	100	–	–	﹤0.01%	14382
2024 Q3	$100	Buy	+100	New	+$111	﹤0.01%	14090
2023 Q2	–	Sell	-1,600	Closed	-$2.34K	–	14829
2023 Q1	$2.34K	Buy	1,600 +1,400	+700%	+$2.68K	﹤0.01%	14162
2022 Q4	$324	Buy	+200	New	+$460	﹤0.01%	14692

Citadel Advisors's KRON Position: Q1 2025 in Review

Citadel Advisors sold out of Kronos Bio (KRON) in Q1 2025, closing a stake of 186,711 shares — an estimated $180K sold.

Citadel Advisors first reported a position in KRON in Q4 2020 and held it in 17 quarters. The position peaked at $27.9M in Q4 2020. 47 funds tracked by Wall St. Rank hold KRON as of Q1 2025.

Citadel Advisors reported no remaining Kronos Bio position as of Q1 2025 after selling out during the quarter.
Citadel Advisors sold 186,711 Kronos Bio shares in Q1 2025, an estimated $180K.
Citadel Advisors first reported a position in Kronos Bio in Q4 2020 and held it in 17 quarters.
Citadel Advisors's Kronos Bio position peaked at $27.9M in Q4 2020.
47 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.